Practicing At
Specialties
Endocrinology, Internal Medicine
Accepting New Patients
Yes
Languages Spoken
Hindi, English
Provider Background
Areas of Interest
Endocrinology
Associations & Organizations
- Member, Alpha Omega Alpha honor society (AOA)
- Elected member, Association of Pathology Chairs Honor Society
- Research Award, Asians in Medicine (AIM), S.U.N.Y.
Publications
- Bhasin, R., Arce, F.C. and Pasmantier, R. “ Hypoglycemia associated with Use of gatifloxacin” Amer. J. Med. Sci. 330/5, 250-253 (2005).
- Arce, F.C., Bhasin, R., and Pasmantier, R. “ Severe Hyperglycemia in Non-diabetic patients receiving Gatifloxacin.” Endocrine Practice 10(1), 40-44 (2004).
- Bhasin, R., Gregori, L., Morozov, I., and Goldgaber, D. “ A Processing Pathway for Amyloid Beta Protein Precursor Generates a Secreted Form With an Intact Carboxyl Terminus.” Amyloid: J.exp. Clin. Invest. 1, 221-231 (1994).
- Gregori, L., Bhasin, R., and Goldgaber, D. “ Ubiquitin-mediated degradation pathway degrades the extracellular but not the intracellular form of amyloid beta protein precursor. Biochem. Biophys. Res. Commun. 203 (3), 1731-1738, (1994).
- Schwarzman, A.L., Gregori, L., Vitek, M.P., Lyubski, S., Stritmatter, W.J., Enghilde, J.J., Bhasin, R., Silverman, J., Weigraber, K.H., Coyle, P.K., et. al. “Transthyretin sequesters amyloid beta protein precursor and prevents amyloid formation.” Proc. Natl. Acad. Sci. (USA) 91 (18), 8368-8372.
- Goldgaber, D., Schwarzman, A.L., Bhasin, R., Gregori, L., Schemchel, D., Saunders, A.M., Roses, A.D., and Stritmatter, W.J. “Sequestration of amyloid beta peptide.” Annals of the New York Academy of Sciences, 695, 139-143, (1993).
- Stritmatter, W.J., Huang, D.Y., Bhasin, R., Roses, A.D. and Goldgaber, D. “Avid binding of beta amyloid to it’s own precursor.” Exp. Neurol. 122(2), 327-334, (1993).
Previous Organizations & Titles
- Private Practice in Endocrinology
- Contract Physician, VA
- Contract Physician, Emergency Room, VA
Medical School
Renaissance School of Medicine at Stony Brook University
Board Certification
American Board of Internal Medicine Endocrinology & Metabolism American Board of Internal Medicine
Insurances Accepted
-
Aetna
-
Aetna Better Health aka Aetna MyCare
-
Aetna Medicare (COPC Senior Care Advantage Participant)
-
Anthem Blue Cross Blue Shield
-
BCMH
-
Caresource Marketplace
-
Cigna
-
Coventry-First Health
-
HealthSmart
-
Humana Commercial
-
Humana Medicare (COPC Senior Care Advantage Participant)
-
Medicaid
-
Medical Mutual of Ohio (MMO)
-
Medical Mutual OhioHealth HMO
-
Medicare
-
MediGold (COPC Senior Care Advantage Participant)
-
Meritain
-
Molina Medicaid - Established Patients Only
-
Mt.Carmel Health Partners Trinity Health Plan
-
Multiplan
-
Ohio Health Choice (OHCP)
-
OhioHealthy
-
OSCAR Buckeye Health
-
OSU Health Plans
-
PHCS
-
PPO Connect
-
Railroad Medicare
-
Tricare Prime Remote-PCP/SCP Network Plan
-
Tricare Standard
-
Trinity Health Plan - Aetna Administered
-
UMWA
-
UnitedHealthcare
Virtual Telehealth Visits
Discover how to have a virtual appointment with your COPC provider.
Get Setup Today
Romi Bhasin, MD, PhD, FACE
Columbus Endocrinology
Male
Endocrinology, Internal Medicine
Renaissance School of Medicine at Stony Brook University
American Board of Internal Medicine Endocrinology & Metabolism American Board of Internal Medicine
Hindi, English
Yes
- Member, Alpha Omega Alpha honor society (AOA)
- Elected member, Association of Pathology Chairs Honor Society
- Research Award, Asians in Medicine (AIM), S.U.N.Y.
- Bhasin, R., Arce, F.C. and Pasmantier, R. “ Hypoglycemia associated with Use of gatifloxacin” Amer. J. Med. Sci. 330/5, 250-253 (2005).
- Arce, F.C., Bhasin, R., and Pasmantier, R. “ Severe Hyperglycemia in Non-diabetic patients receiving Gatifloxacin.” Endocrine Practice 10(1), 40-44 (2004).
- Bhasin, R., Gregori, L., Morozov, I., and Goldgaber, D. “ A Processing Pathway for Amyloid Beta Protein Precursor Generates a Secreted Form With an Intact Carboxyl Terminus.” Amyloid: J.exp. Clin. Invest. 1, 221-231 (1994).
- Gregori, L., Bhasin, R., and Goldgaber, D. “ Ubiquitin-mediated degradation pathway degrades the extracellular but not the intracellular form of amyloid beta protein precursor. Biochem. Biophys. Res. Commun. 203 (3), 1731-1738, (1994).
- Schwarzman, A.L., Gregori, L., Vitek, M.P., Lyubski, S., Stritmatter, W.J., Enghilde, J.J., Bhasin, R., Silverman, J., Weigraber, K.H., Coyle, P.K., et. al. “Transthyretin sequesters amyloid beta protein precursor and prevents amyloid formation.” Proc. Natl. Acad. Sci. (USA) 91 (18), 8368-8372.
- Goldgaber, D., Schwarzman, A.L., Bhasin, R., Gregori, L., Schemchel, D., Saunders, A.M., Roses, A.D., and Stritmatter, W.J. “Sequestration of amyloid beta peptide.” Annals of the New York Academy of Sciences, 695, 139-143, (1993).
- Stritmatter, W.J., Huang, D.Y., Bhasin, R., Roses, A.D. and Goldgaber, D. “Avid binding of beta amyloid to it’s own precursor.” Exp. Neurol. 122(2), 327-334, (1993).
- Private Practice in Endocrinology
- Contract Physician, VA
- Contract Physician, Emergency Room, VA